Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin.
about
Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infantsOral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infantsOral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infantsLactoferrin: A Modulator for Immunity against Tuberculosis Related Granulomatous PathologyLactoferrin for prevention of neonatal sepsisInfluence of bovine lactoferrin on expression of presentation molecules on BCG-infected bone marrow derived macrophagesCan lactoferrin prevent neonatal sepsis and necrotizing enterocolitis?Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants.Lactoferrin and prematurity: a promising milk protein?Lactoferrin: Balancing Ups and Downs of Inflammation Due to Microbial Infections.Immunomodulatory effects of recombinant lactoferrin during MRSA infection.The effect of recombinant human lactoferrin from the milk of transgenic cows on Salmonella enterica serovar typhimurium infection in mice.Lactoferrin in a Context of Inflammation-Induced Pathology.Effects of lactoferrin supplementation on ileal and total tract nutrient digestibility, gastrointestinal microbial populations, and immune characteristics of ileal cannulated, healthy, adult dogs.
P2860
Q24188043-4645B97B-E9AD-472A-9B36-5032C0405570Q24235455-5F4BF693-FBAD-4E70-A751-3AED7918305DQ24236014-27F8261B-EA96-49C5-9A2D-81E80983D4BAQ26770855-65B5D35C-0DAD-4DE1-8462-4C8EDD787F2FQ35042515-2D90AE41-695E-47FD-BFDC-BF4D74C22F90Q37060662-5FB29BEA-E35F-4790-A258-163C9A9AA14BQ37503327-699004F7-9C4C-428A-908C-E1BB9ECF2BC7Q38704288-B33ED028-2127-4470-8BC0-C4A88B8B2005Q39085772-B09BA376-A581-4C13-98FD-6954A71C90CFQ39159902-2E0EAFE7-1B0D-46DC-A958-46A9698A4C1EQ39486464-AEBF93EF-C8E2-4908-AB1B-C5B37C223D5EQ40951693-EF5F2001-B0B0-4E47-91BF-F90908E84B72Q46256576-C03A96AD-2942-47EB-97F9-0131AF849715Q46984427-03D27D01-B99E-4C6F-8D38-899B1A57AFDC
P2860
Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Enhanced clearance of Escheric ...... lophosphamide and lactoferrin.
@en
Enhanced clearance of Escheric ...... lophosphamide and lactoferrin.
@nl
type
label
Enhanced clearance of Escheric ...... lophosphamide and lactoferrin.
@en
Enhanced clearance of Escheric ...... lophosphamide and lactoferrin.
@nl
prefLabel
Enhanced clearance of Escheric ...... lophosphamide and lactoferrin.
@en
Enhanced clearance of Escheric ...... lophosphamide and lactoferrin.
@nl
P1476
Enhanced clearance of Escheric ...... clophosphamide and lactoferrin
@en
P2093
Marian L Kruzel
Michal Zimecki
P304
P356
10.1016/J.INTIMP.2004.05.002
P577
2004-09-01T00:00:00Z